STAAR Surgical Announces Closing of Common Stock Offering
August 10 2018 - 9:45AM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses and companion
delivery systems for the eye, announced today the closing of the
previously announced underwritten public offering of 1,999,850
shares of its common stock, which includes the full exercise of the
underwriter’s option to purchase up to an additional 260,850
shares, at a price to the public of $39.00 per share. The gross
proceeds of the offering, before deducting underwriting commissions
and offering expenses, were $77,994,150. Canaccord Genuity acted as
the sole book-running manager for the offering.
All shares of the common stock offered by STAAR were offered
pursuant to an effective shelf registration statement (including a
prospectus) on Form S-3 previously filed with the Securities and
Exchange Commission (“SEC”). Copies of the prospectus supplement
and base prospectus relating to the offering may be obtained from
Canaccord Genuity LLC, Attn: Syndicate Department, 99 High Street,
12th Floor, Boston, MA 02110, toll-free phone: 1-800-225-6201 or by
e-mail at prospectus@canaccordgenuity.com.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under
the securities laws of any such state.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180810005247/en/
Investors & Media:EVC GroupBrian Moore,
310-579-6199Doug Sherk, 415-652-9100
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Aug 2024 to Sep 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Sep 2023 to Sep 2024